Loading...

H100 Group AB N

GS9.FXETRA
Healthcare
Medical - Healthcare Information Services
0.13
-0.03(-15.75%)
German Market opens in 45h 4m

H100 Group AB N Fundamental Analysis

H100 Group AB N (GS9.F) shows weak financial fundamentals with a PE ratio of -1.63, profit margin of -5.49%, and ROE of -25.24%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position612.58%
PEG Ratio-0.00
Current Ratio2.47

Areas of Concern

ROE-25.24%
Operating Margin-1.71%
We analyze GS9.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -509.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-509.4/100

We analyze GS9.F's fundamental strength across five key dimensions:

Efficiency Score

Weak

GS9.F struggles to generate sufficient returns from assets.

ROA > 10%
-14.68%

Valuation Score

Excellent

GS9.F trades at attractive valuation levels.

PE < 25
-1.63
PEG Ratio < 2
-0.00

Growth Score

Weak

GS9.F faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

GS9.F maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
2.47

Profitability Score

Weak

GS9.F struggles to sustain strong margins.

ROE > 15%
-2523.55%
Net Margin ≥ 15%
-5.49%
Positive Free Cash Flow
No

Key Financial Metrics

Is GS9.F Expensive or Cheap?

P/E Ratio

GS9.F trades at -1.63 times earnings. This suggests potential undervaluation.

-1.63

PEG Ratio

When adjusting for growth, GS9.F's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values H100 Group AB N at 0.26 times its book value. This may indicate undervaluation.

0.26

EV/EBITDA

Enterprise value stands at -127.33 times EBITDA. This is generally considered low.

-127.33

How Well Does GS9.F Make Money?

Net Profit Margin

For every $100 in sales, H100 Group AB N keeps $-5.49 as profit after all expenses.

-5.49%

Operating Margin

Core operations generate -1.71 in profit for every $100 in revenue, before interest and taxes.

-1.71%

ROE

Management delivers $-25.24 in profit for every $100 of shareholder equity.

-25.24%

ROA

H100 Group AB N generates $-14.68 in profit for every $100 in assets, demonstrating efficient asset deployment.

-14.68%

Following the Money - Real Cash Generation

Operating Cash Flow

H100 Group AB N generates limited operating cash flow of $-48.37M, signaling weaker underlying cash strength.

$-48.37M

Free Cash Flow

H100 Group AB N generates weak or negative free cash flow of $-48.37M, restricting financial flexibility.

$-48.37M

FCF Per Share

Each share generates $-0.14 in free cash annually.

$-0.14

FCF Yield

GS9.F converts -0.54% of its market value into free cash.

-0.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.63

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.26

vs 25 benchmark

P/S Ratio

Price to sales ratio

161.83

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.25

vs 25 benchmark

ROA

Return on assets percentage

-0.15

vs 25 benchmark

ROCE

Return on capital employed

-0.05

vs 25 benchmark

How GS9.F Stacks Against Its Sector Peers

MetricGS9.F ValueSector AveragePerformance
P/E Ratio-1.6328.81 Better (Cheaper)
ROE-25.24%643.00% Weak
Net Margin-549.46%-44312.00% (disorted) Weak
Debt/Equity0.000.36 Strong (Low Leverage)
Current Ratio2.474.50 Strong Liquidity
ROA-14.68%-17799.00% (disorted) Weak

GS9.F outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews H100 Group AB N's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ